These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

389 related items for PubMed ID: 3540121

  • 1. Graft vs graft reaction resulting in the elimination of maternal cells in a SCID patient with maternofetal GVHd after an HLA identical bone marrow transplantation.
    Le Deist F, Raffoux C, Griscelli C, Fischer A.
    J Immunol; 1987 Jan 15; 138(2):423-7. PubMed ID: 3540121
    [Abstract] [Full Text] [Related]

  • 2. Bone marrow transplantation from genetically HLA-nonidentical donors in children with fatal inherited disorders excluding severe combined immunodeficiencies: use of two monoclonal antibodies to prevent graft rejection.
    Jabado N, Le Deist F, Cant A, De Graeff-Meeders ER, Fasth A, Morgan G, Vellodi A, Hale G, Bujan W, Thomas C, Cavazzana-Calvo M, Wijdenes J, Fischer A.
    Pediatrics; 1996 Sep 15; 98(3 Pt 1):420-8. PubMed ID: 8784367
    [Abstract] [Full Text] [Related]

  • 3. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP, Griscelli C, Fischer A.
    Eur J Immunol; 1986 Feb 15; 16(2):117-22. PubMed ID: 3514234
    [Abstract] [Full Text] [Related]

  • 4. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT).
    Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A.
    Exp Hematol; 1995 Dec 15; 23(14):1667-75. PubMed ID: 8542963
    [Abstract] [Full Text] [Related]

  • 5. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T, Gillespie G, Schrama E, Falkenburg JH, Moss P, Goulmy E.
    Nat Med; 1999 Jul 15; 5(7):839-42. PubMed ID: 10395333
    [Abstract] [Full Text] [Related]

  • 6. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA.
    Dan Med Bull; 2002 May 15; 49(2):89-108. PubMed ID: 12064093
    [Abstract] [Full Text] [Related]

  • 7. In vitro analysis of donor bone marrow following monoclonal antibody treatment for the prevention of acute graft versus host disease.
    Kohler PC, Erickson C, Finlay JL, Trigg ME, Edwards B, Hong R, Hank JA, Billing R, Bozdech M, Sondel PM.
    Cancer Res; 1986 Oct 15; 46(10):5413-8. PubMed ID: 3530439
    [Abstract] [Full Text] [Related]

  • 8. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.
    Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA.
    Bone Marrow Transplant; 1997 May 15; 19(10):1001-9. PubMed ID: 9169644
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic bone marrow transplantation: relation between chimaerism and immunity.
    Vossen J.
    Verh K Acad Geneeskd Belg; 1998 May 15; 60(2):111-43; discussion 143-5. PubMed ID: 9703764
    [Abstract] [Full Text] [Related]

  • 10. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW, Shamim F, Hamon M, Macdonald ID, Prentice HG.
    Exp Hematol; 1995 Dec 15; 23(14):1530-4. PubMed ID: 8542943
    [Abstract] [Full Text] [Related]

  • 11. Dissociation between onset of natural killer E-rosette forming cells and of T3-positive cells following HLA-mismatched T cell depleted bone marrow transplantation.
    De Villartay JP, Le Deist F, Griscelli C, Fischer A.
    Clin Exp Immunol; 1987 Feb 15; 67(2):406-14. PubMed ID: 3301094
    [Abstract] [Full Text] [Related]

  • 12. Serial transplantation resulting in tolerance to an unrelated cord blood graft.
    Goebel WS, Nelson RP, Brahmi Z, Gowan DJ, Towell PJ, Robertson KA, Haut PR.
    Transplantation; 2006 Jun 15; 81(11):1596-9. PubMed ID: 16770250
    [Abstract] [Full Text] [Related]

  • 13. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 15; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 14. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH, Schiff SE, Sampson HA, Schiff RI, Markert ML, Knutsen AP, Hershfield MS, Huang AT, Mickey GH, Ward FE.
    J Immunol; 1986 Apr 01; 136(7):2398-407. PubMed ID: 2869085
    [Abstract] [Full Text] [Related]

  • 15. Phenotype and function of engrafted maternal T cells in patients with severe combined immunodeficiency.
    Thompson LF, O'Connor RD, Bastian JF.
    J Immunol; 1984 Nov 01; 133(5):2513-7. PubMed ID: 6090535
    [Abstract] [Full Text] [Related]

  • 16. Identification by HLA typing of intrauterine-derived maternal T cells in four patients with severe combined immunodeficiency.
    Pollack MS, Kirkpatrick D, Kapoor N, Dupont B, O'Reilly RJ.
    N Engl J Med; 1982 Sep 09; 307(11):662-6. PubMed ID: 7050708
    [No Abstract] [Full Text] [Related]

  • 17. Graft-versus-host disease after marrow transplantation.
    Storb R.
    Prog Clin Biol Res; 1986 Sep 09; 224():139-57. PubMed ID: 3540990
    [Abstract] [Full Text] [Related]

  • 18. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE, Buckley RH.
    J Immunol; 1987 Apr 01; 138(7):2088-94. PubMed ID: 2881966
    [Abstract] [Full Text] [Related]

  • 19. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E, Wang KS, Hochberg EP, Canning C, Alyea EP, Soiffer RJ, Ritz J.
    Clin Cancer Res; 2002 Jul 01; 8(7):2052-60. PubMed ID: 12114403
    [Abstract] [Full Text] [Related]

  • 20. Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency.
    Palmer K, Green TD, Roberts JL, Sajaroff E, Cooney M, Parrott R, Chen DF, Reinsmoen NL, Buckley RH.
    J Allergy Clin Immunol; 2007 Aug 01; 120(2):423-8. PubMed ID: 17481714
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.